Triple

T18325647
Position Surface form Disambiguated ID Type / Status
Subject TIBCO Software E438997 entity
Predicate hasProduct P3585 FINISHED
Object TIBCO Jaspersoft NE NERFINISHED

How this triple was built (3 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: TIBCO Jaspersoft | Statement: [TIBCO Software, hasProduct, TIBCO Jaspersoft]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: TIBCO Jaspersoft
Context triple: [TIBCO Software, hasProduct, TIBCO Jaspersoft]
  • A. TIBCO Software
    TIBCO Software is an enterprise software company known for its real-time data integration, analytics, and event-processing solutions for businesses.
  • B. Jasper Technologies
    Jasper Technologies is a cloud-based Internet of Things (IoT) platform provider known for enabling companies to manage and monetize connected devices and services.
  • C. IBM Cognos Analytics
    IBM Cognos Analytics is a business intelligence and data analytics platform that enables users to visualize, explore, and report on data for informed decision-making.
  • D. Eclipse BIRT
    Eclipse BIRT is an open-source reporting and business intelligence toolset for creating data visualizations and reports, primarily used within Java and web applications.
  • E. Ebixa
    Ebixa is a brand-name medication containing memantine, used primarily to treat moderate to severe Alzheimer's disease.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: TIBCO Jaspersoft
Target entity description: TIBCO Jaspersoft is a business intelligence and reporting platform that enables users to create, embed, and distribute interactive reports, dashboards, and data visualizations.
  • A. TIBCO Software chosen
    TIBCO Software is an enterprise software company known for its real-time data integration, analytics, and event-processing solutions for businesses.
  • B. Jasper Technologies
    Jasper Technologies is a cloud-based Internet of Things (IoT) platform provider known for enabling companies to manage and monetize connected devices and services.
  • C. IBM Cognos Analytics
    IBM Cognos Analytics is a business intelligence and data analytics platform that enables users to visualize, explore, and report on data for informed decision-making.
  • D. Eclipse BIRT
    Eclipse BIRT is an open-source reporting and business intelligence toolset for creating data visualizations and reports, primarily used within Java and web applications.
  • E. Ebixa
    Ebixa is a brand-name medication containing memantine, used primarily to treat moderate to severe Alzheimer's disease.
  • F. None of above.

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d8b916a2d081909e249e4902f6aad9 completed April 10, 2026, 8:47 a.m.
NER Named-entity recognition batch_69e50aaa66ac819082ec718e8329e0cc completed April 19, 2026, 5:02 p.m.
Created at: April 10, 2026, 10:36 a.m.